"Clinical Effects of the Self-administered Subcutaneous Complement Inhi" by James F. Howard, Richard J. Nowak et al.
 

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.

Document Type

Journal Article

Publication Date

2-17-2020

Journal

JAMA Neurology

DOI

10.1001/jamaneurol.2019.5125

Comments

Online ahead of print

Peer Reviewed

1

Find in your library

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 148
    • Patent Family Citations: 3
    • Policy Citations: 1
  • Usage
    • Abstract Views: 37
  • Captures
    • Readers: 213
  • Mentions
    • News Mentions: 1
  • Social Media
    • Shares, Likes & Comments: 164
see details

Share

COinS